Wyden Turns Up Heat on Novartis in Cohen Controversy

Drug Industry Daily
A A
In the latest development in the Michael Cohen-Novartis scandal, the U.S. Senate Committee on Finance pressured Novartis CEO Vasant Narasimhan for contracts and communications made between the pharma company and the president’s attorney.

To View This Article:

Login

Subscribe To Drug Industry Daily